| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.41B | 1.15B | 895.40M | 636.40M | 535.82M |
| Gross Profit | 622.11M | 327.89M | 271.65M | 168.20M | 134.35M |
| EBITDA | 227.88M | 165.59M | 124.02M | 60.29M | 58.53M |
| Net Income | 170.03M | 118.83M | 85.98M | 39.40M | 38.32M |
Balance Sheet | |||||
| Total Assets | 4.79B | 3.73B | 2.95B | 2.36B | 2.12B |
| Cash, Cash Equivalents and Short-Term Investments | 2.02B | 1.18B | 1.35B | 774.17M | 664.74M |
| Total Debt | 119.98M | 119.54M | 128.69M | 128.61M | 128.53M |
| Total Liabilities | 3.78B | 2.94B | 2.29B | 1.94B | 1.69B |
| Stockholders Equity | 1.01B | 794.00M | 661.03M | 421.66M | 426.08M |
Cash Flow | |||||
| Free Cash Flow | 402.62M | 300.89M | 335.03M | 206.61M | 173.13M |
| Operating Cash Flow | 408.08M | 305.12M | 338.19M | 208.94M | 175.28M |
| Investing Cash Flow | -366.90M | -243.69M | -493.81M | -193.38M | -183.01M |
| Financing Cash Flow | 411.00K | -4.23M | 130.95M | 2.18M | 1.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $1.97B | 7.31 | 38.04% | 0.82% | 8.71% | 17.26% | |
77 Outperform | $1.83B | 12.16 | 18.27% | ― | 22.51% | 2.19% | |
76 Outperform | $1.05B | 11.55 | 11.29% | 4.59% | 13.35% | 16.56% | |
73 Outperform | $2.04B | 3.54 | 75.10% | ― | ― | ― | |
69 Neutral | $1.75B | 17.66 | 7.08% | 2.88% | 16.22% | 69.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | $708.85M | 27.78 | 10.96% | ― | 38.50% | ― |
On December 30, 2025, Skyward Specialty entered into a new unsecured senior delayed draw term loan facility totaling $300 million, split between Tranche A maturing January 1, 2028 and Tranche B maturing July 2, 2029, with pricing tied to term SOFR or a base rate plus a margin, and customary covenants on leverage, capital, ratings and liquidity, as well as a related guaranty from most non-insurance subsidiaries and an amendment to its existing credit agreement to permit pre-funding of revolving loans. Using proceeds from this new facility and its existing credit agreement, the company completed the previously announced acquisition of U.K.-based Apollo Group Holdings Limited on the January 2, 2026 closing date, paying roughly $555 million through $371 million in cash and the issuance of 3.68 million common shares, a move that expands Skyward Specialty’s presence at Lloyd’s of London and broadens its product and geographic reach in specialty insurance markets.
The most recent analyst rating on (SKWD) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Skyward Specialty Insurance Group, Inc. stock, see the SKWD Stock Forecast page.